US FDA approves Moderna’s first mRNA seasonal flu vaccine
The U.S. Food and Drug Administration has approved Moderna’s mFlusiva seasonal flu vaccine for adults aged 50 and older. It received traditional approval for people aged 50 to 64 and accelerated approval…
Ashin Xavier: interesting
IO Repro: Repro test v4 after fix 2 Oct. Safe to trash.
IO Repro: Repro test v3 after fix 2 Oct. Safe to trash.
IO Repro: Repro test after fix 2 Oct. Safe to trash.